Primary liver cancer is a major global health challenge, of which hepatocellular carcinoma is the most common. For patients with advanced liver cancer, sorafenib is a first-line targeted drug that occupies a dominant position in clinical applications. Sorafeni... ...

请注册登录后继续浏览